| hsa-miR-455-3p |
This research explores the variation in miRNA profiles within exosomes derived f… |
Serum Maternal Exosomal |
GDM(n=19),Normal Glucose Tolerance(n=62)
|
Western Blotting |
before 18th gestational weeks |
|
Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM |
2024 |
The Journal of Clinical Endocrinology & Metabolism |
38127956 |
Mechanism |
| hsa-miR-149-3p |
This research explores the variation in miRNA profiles within exosomes derived f… |
Serum Maternal Exosomal |
GDM(n=19),Normal Glucose Tolerance(n=62)
|
Western Blotting |
before 18th gestational weeks |
|
Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM |
2024 |
The Journal of Clinical Endocrinology & Metabolism |
38127956 |
Mechanism |
| BAFF |
The study investigates the roles of BAFF and APRIL in predicting the development… |
Serum |
GDM(n=10),Normal Glucose Tolerance(n=62)
|
ELISA；RT-qPCR |
6th to 12th gestational weeks |
Logistic Regression |
Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus |
2024 |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews |
38653036 |
Risk factor |
| APRIL |
The study investigates the roles of BAFF and APRIL in predicting the development… |
Serum |
GDM(n=10),Normal Glucose Tolerance(n=62)
|
ELISA；RT-qPCR |
6th to 12th gestational weeks |
Logistic Regression |
Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus |
2024 |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews |
38653036 |
Risk factor |
| VitB1 |
The study investigates the relationship between maternal B vitamins (B1, B6, and… |
Serum |
GDM(n=121),Normal Glucose Tolerance(n=944)
|
Electro-Chemiluminescent Assays |
8th to 15th gestational weeks |
Multivariable Logistic Regression；Restricted Cubic Spline (RCS) Regression |
The Association between Maternal B Vitamins in Early Pregnancy and Gestational Diabetes Mellitus: A Prospective Cohort Study |
2022 |
Nutrients |
36501046 |
Risk factor |
| VitB6 |
The study investigates the relationship between maternal B vitamins (B1, B6, and… |
Serum |
GDM group (n = 121) and non-GDM group (n = 944)
|
Electro-Chemiluminescent Assays |
8th to 15th gestational weeks |
Multivariable Logistic Regression；Restricted Cubic Spline (RCS) Regression |
The Association between Maternal B Vitamins in Early Pregnancy and Gestational Diabetes Mellitus: A Prospective Cohort Study |
2022 |
Nutrients |
36501046 |
Risk factor |
| FT3 to FT4 ratio |
This study explored the prospective associations between thyroid markers in earl… |
Serum |
GDM(n=298),Normal Glucose Tolerance(n=585)
|
Chemiluminescent Immunoassays |
10.4 ± 2.0 gestational weeks |
|
A Prospective Study of Early-pregnancy Thyroid Markers, Lipid Species, and Risk of Gestational Diabetes Mellitus |
2022 |
Journal of Clinical Endocrinology & Metabolism |
34453541 |
Risk factor |
| ALP |
This study explored the relationship between early maternal alkaline phosphatase… |
Serum |
GDM(n=169),Normal Glucose Tolerance(n=1904);Q1(13.0–38U/L,n=519),Q2 (38–44U/L,n=518),Q3 (44–50U/L,n=517),Q4 (>50U/L,n=519)
|
Colorimetric method |
16±2 gestational weeks |
|
Early maternal circulating alkaline phosphatase with subsequent gestational diabetes mellitus and glucose regulation: a prospective cohort study in China |
31115769 |
Endocrine |
31115769 |
Risk factor |
| ALT |
This study investigated the relationship between alanine aminotransferase (ALT)… |
Serum |
GDM(n=1332),Normal Glucose Tolerance(n=16027)
|
Enzymatic Methods |
4th to 12th gestational weeks |
|
Plasma Levels of Alanine Aminotransferase in the First Trimester Identify High Risk Chinese Women for Gestational Diabetes |
2016 |
Scientific Reports |
27264612 |
Risk factor |
| FT3 |
This study explored the relationship between thyroid markers and gestational dia… |
Serum |
9.8 ± 1.9, 17.0 ± 4.0 and 32.0 ± 2.8 gestational weeks
|
Chemiluminescent Microparticle Immunoassay |
9.8 ± 1.9, 17.0 ± 4.0 and 32.0 ± 2.8 gestational weeks |
|
A longitudinal study of thyroid markers during pregnancy and the risk of gestational diabetes mellitus and post-partum glucose metabolism |
2021 |
Diabetes-metabolism Research And Reviews |
33486811 |
Risk factor |
